195 related articles for article (PubMed ID: 16210667)
21. Mast Cells Contribute to Porphyromonas gingivalis-induced Bone Loss.
Malcolm J; Millington O; Millhouse E; Campbell L; Adrados Planell A; Butcher JP; Lawrence C; Ross K; Ramage G; McInnes IB; Culshaw S
J Dent Res; 2016 Jun; 95(6):704-10. PubMed ID: 26933137
[TBL] [Abstract][Full Text] [Related]
22. Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice.
Piliponsky AM; Chen CC; Grimbaldeston MA; Burns-Guydish SM; Hardy J; Kalesnikoff J; Contag CH; Tsai M; Galli SJ
Am J Pathol; 2010 Feb; 176(2):926-38. PubMed ID: 20035049
[TBL] [Abstract][Full Text] [Related]
23. Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice.
Zhang J; Chen H; Liu L; Sun J; Shi MA; Sukhova GK; Shi GP
Cardiovasc Res; 2012 Dec; 96(3):543-51. PubMed ID: 22871590
[TBL] [Abstract][Full Text] [Related]
24. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.
Salvatore CM; Fonseca-Aten M; Katz-Gaynor K; Gomez AM; Mejias A; Somers C; Chavez-Bueno S; McCracken GH; Hardy RD
Infect Immun; 2007 Jan; 75(1):236-42. PubMed ID: 17074851
[TBL] [Abstract][Full Text] [Related]
25. Parasitic infection improves survival from septic peritonitis by enhancing mast cell responses to bacteria in mice.
Sutherland RE; Xu X; Kim SS; Seeley EJ; Caughey GH; Wolters PJ
PLoS One; 2011; 6(11):e27564. PubMed ID: 22110673
[TBL] [Abstract][Full Text] [Related]
26. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis.
Fukuda K; Ohbayashi M; Morohoshi K; Zhang L; Liu FT; Ono SJ
J Allergy Clin Immunol; 2009 Oct; 124(4):827-33.e2. PubMed ID: 19660804
[TBL] [Abstract][Full Text] [Related]
27. Regulation of hepatocyte growth factor in mice with pneumonia by peptidases and trans-alveolar flux.
Raymond WW; Xu X; Nimishakavi S; Le C; McDonald DM; Caughey GH
PLoS One; 2015; 10(5):e0125797. PubMed ID: 25938594
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis.
Mize MT; Sun XL; Simecka JW
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986888
[TBL] [Abstract][Full Text] [Related]
29. Mast cells play an important role in chlamydia pneumoniae lung infection by facilitating immune cell recruitment into the airway.
Chiba N; Shimada K; Chen S; Jones HD; Alsabeh R; Slepenkin AV; Peterson E; Crother TR; Arditi M
J Immunol; 2015 Apr; 194(8):3840-51. PubMed ID: 25754739
[TBL] [Abstract][Full Text] [Related]
30. Mast cells impair host defense during murine Streptococcus pneumoniae pneumonia.
van den Boogaard FE; Brands X; Roelofs JJ; de Beer R; de Boer OJ; van 't Veer C; van der Poll T
J Infect Dis; 2014 Nov; 210(9):1376-84. PubMed ID: 24823624
[TBL] [Abstract][Full Text] [Related]
31. Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis.
Zhou JS; Xing W; Friend DS; Austen KF; Katz HR
J Exp Med; 2007 Nov; 204(12):2797-802. PubMed ID: 17998392
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase-2 and -9 expression increases in Mycoplasma-infected airways but is not required for microvascular remodeling.
Baluk P; Raymond WW; Ator E; Coussens LM; McDonald DM; Caughey GH
Am J Physiol Lung Cell Mol Physiol; 2004 Aug; 287(2):L307-17. PubMed ID: 15075248
[TBL] [Abstract][Full Text] [Related]
33. Class-specific antibody responses to Mycoplasma pulmonis in sera and lungs of infected and vaccinated mice.
Taylor G; Howard CJ
Infect Immun; 1980 Sep; 29(3):1160-8. PubMed ID: 7429631
[TBL] [Abstract][Full Text] [Related]
34. Mast cell-associated TNF promotes dendritic cell migration.
Suto H; Nakae S; Kakurai M; Sedgwick JD; Tsai M; Galli SJ
J Immunol; 2006 Apr; 176(7):4102-12. PubMed ID: 16547246
[TBL] [Abstract][Full Text] [Related]
35. Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice.
Reber LL; Marichal T; Mukai K; Kita Y; Tokuoka SM; Roers A; Hartmann K; Karasuyama H; Nadeau KC; Tsai M; Galli SJ
J Allergy Clin Immunol; 2013 Oct; 132(4):881-8.e1-11. PubMed ID: 23915716
[TBL] [Abstract][Full Text] [Related]
36. Immunomodulatory properties of Mycoplasma pulmonis. I. Characterization of the immunomodulatory activity.
Romero-Rojas A; Ponce-Hernández C; Ciprián A; Estrada-Parra S; Hadden JW
Int Immunopharmacol; 2001 Sep; 1(9-10):1679-88. PubMed ID: 11562060
[TBL] [Abstract][Full Text] [Related]
37. Surfactant dysfunction in SP-A-/- and iNOS-/- mice with mycoplasma infection.
Hickman-Davis JM; Wang Z; Fierro-Perez GA; Chess PR; Page GP; Matalon S; Notter RH
Am J Respir Cell Mol Biol; 2007 Jan; 36(1):103-13. PubMed ID: 16917077
[TBL] [Abstract][Full Text] [Related]
38. Profiling of cellular immune responses to Mycoplasma pulmonis infection in C57BL/6 and DBA/2 mice.
Boonyarattanasoonthorn T; Elewa YHA; Tag-El-Din-Hassan HT; Morimatsu M; Agui T
Infect Genet Evol; 2019 Sep; 73():55-65. PubMed ID: 31026602
[TBL] [Abstract][Full Text] [Related]
39. Immunological analysis and pathological examination of gnotobiotic mice monoassociated with Mycoplasma pneumoniae.
Sekine H; Taguchi H; Watanabe H; Kawai S; Fujioka Y; Goto H; Kobayashi H; Kamiya S
J Med Microbiol; 2009 Jun; 58(Pt 6):697-705. PubMed ID: 19429744
[TBL] [Abstract][Full Text] [Related]
40. [Protective immune responses induced by intranasal immunization with Mycoplasma pneumoniae P1C-IL-2 fusion DNA vaccine in mice].
Zhu C; Yu M; Gao S; Zeng Y; You X; Wu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):585-8. PubMed ID: 23746241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
